论文部分内容阅读
目的探究阿奇霉素联合枫蓼肠胃康治疗急性肠炎的临床疗效。方法选取河南省石油勘探局双河医院2011年5—11月收治的急性肠炎患者68例,随机分为试验组和对照组,每组34例。试验组患者在基础治疗的同时给予阿奇霉素联合枫蓼肠胃康治疗,对照组患者在基础治疗的同时仅给予阿奇霉素治疗。比较两组患者的临床疗效。结果试验组患者临床总有效率(97.1%)高于对照组(79.4%),差异有统计学意义(χ2=6.167,P<0.05)。两组患者均未发生肝肾损害等不良反应。结论阿奇霉素联合枫蓼肠胃康治疗急性肠炎的临床疗效显著。
Objective To investigate the clinical efficacy of azithromycin combined with Fengliao Changweikang in the treatment of acute enteritis. Methods Sixty-eight patients with acute enteritis admitted from May 2011 to November 2011 in Shuanghe Hospital of Henan Petroleum Exploration Bureau were randomly divided into experimental group and control group with 34 cases in each group. Patients in the experimental group were given azithromycin combined with Fengliao Weikangkang at the same time as the basic treatment, while those in the control group were treated with azithromycin only at the same time as the basic treatment. The clinical efficacy of the two groups was compared. Results The total effective rate (97.1%) in the trial group was significantly higher than that in the control group (79.4%) (χ2 = 6.167, P <0.05). Two groups of patients did not occur liver and kidney damage and other adverse reactions. Conclusion Azithromycin combined with Fengliao Chang Wei Kang in the treatment of acute enteritis has a significant clinical effect.